Kitov Pharma Ltd (KTOV) Forecast, Price Target & Analyst Ratings

NASDAQ:KTOV

4.17
+0.09 (+2.21%)
At close: Dec 21, 2020
4.11
-0.06 (-1.44%)
After Hours: 12/21/2020, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Kitov Pharma Ltd (KTOV).

Forecast Snapshot

Consensus Price Target

Price Target
N/A
N/A

Next Earnings Forecast

Earnings Estimate
Release DateN/A

ChartMill Buy Consensus

Rating
100.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
N/A
Upside
N/A
From current price of $4.17 to mean target of N/A, Based on 1 analyst forecasts
Low
N/A
Median
N/A
High
N/A

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

 → Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

KTOV Current Analyst RatingKTOV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.2 0.4 0.6 0.8

Analyst Ratings History

KTOV Historical Analyst RatingsKTOV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 0.2 0.4 0.6 0.8

Analyst Ratings Consensus

ChartMill Buy Consensus
100.00%
KTOV was analyzed by 1 analysts. The buy percentage consensus is at 100. So analysts seem to be very confident about KTOV.
In the previous month the buy percentage consensus was at a similar level.
Only 1 analysts analyzed KTOV. So this is just the average opinion of a couple of analysts.
 → Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release DateN/A

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

 → Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

Kitov Pharma Ltd / KTOV Forecast FAQ

How many analysts cover Kitov Pharma Ltd (KTOV) stock?

The number of analysts covering Kitov Pharma Ltd (KTOV) is 1.